ORIGINAL
Descripción de los pacientes que reciben biológicos como primer tratamiento sistémico en el registro BIOBADADERM durante el periodo 2008-2016
Description of Patients Treated with Biologic Drugs as First-Line Systemic Therapy in the BIOBADADERM Registry Between 2008 and 2016
G. Carretero Hernándeza,bC. Ferrándizb,cR. Rivera Díazb,dE. Daudén Tellob,eP. de la Cueva-Dobaob,fF.J. Gómez-Garcíab,gE. Herrera-Ceballosb,hI. Belinchón Romerob,iJ.L. López-Estebaranzb,jM. Alsina Gibertb,kJ.L. Sánchez-Carazob,lM. Ferrán Farrésb,mA. González Quesadaa,b,
J.M. Carrascosa Carrillob,cM. Llamas-Velascob,eM.V. Mendiola Fernándezb,hD. Ruiz Genaob,jC. Muñoz Santosb,kI. García-Dovalb,nM.A. Descalzob,ngrupo de estudio de Biobadaderm
a Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, España
b Unidad de Investigación, Fundación Piel Sana, Academia Española de Dermatología y Venereología, Madrid, España
c Hospital Universitario Germans Trias i Pujol, Universidad Autónoma de Barcelona, Badalona, Barcelona, España
d Hospital Universitario 12 de Octubre, Madrid, España
e Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria La Princesa (IIS-IP), Madrid, España
f Hospital Infanta Leonor, Madrid, España
g Hospital Universitario Reina Sofía, Córdoba, España
h Hospital Universitario Virgen de la Victoria, Málaga, España
i Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, España
j Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, España
k Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, España
l Hospital General Universitario de Valencia, Valencia, España
m Hospital del Mar, Parc de Salut Mar, Barcelona, España
n Hospital General de Granollers, Granollers, Barcelona, España
Ver másLeído
7903
Vecesse ha leído el artículo
2286
Total PDF
5617
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 26 | 7 | 33 |
| 2025 5 | 126 | 31 | 157 |
| 2025 4 | 154 | 20 | 174 |
| 2025 3 | 95 | 22 | 117 |
| 2025 2 | 121 | 39 | 160 |
| 2025 1 | 84 | 27 | 111 |
| 2024 12 | 86 | 33 | 119 |
| 2024 11 | 129 | 47 | 176 |
| 2024 10 | 108 | 46 | 154 |
| 2024 9 | 84 | 25 | 109 |
| 2024 8 | 86 | 46 | 132 |
| 2024 7 | 78 | 28 | 106 |
| 2024 6 | 112 | 41 | 153 |
| 2024 5 | 122 | 34 | 156 |
| 2024 4 | 106 | 30 | 136 |
| 2024 3 | 116 | 41 | 157 |
| 2024 2 | 96 | 30 | 126 |
| 2024 1 | 109 | 29 | 138 |
| 2023 12 | 77 | 11 | 88 |
| 2023 11 | 80 | 32 | 112 |
| 2023 10 | 78 | 34 | 112 |
| 2023 9 | 77 | 28 | 105 |
| 2023 8 | 59 | 22 | 81 |
| 2023 7 | 68 | 37 | 105 |
| 2023 6 | 63 | 25 | 88 |
| 2023 5 | 108 | 24 | 132 |
| 2023 4 | 84 | 31 | 115 |
| 2023 3 | 107 | 28 | 135 |
| 2023 2 | 83 | 23 | 106 |
| 2022 1 | 71 | 30 | 101 |
| 2022 12 | 113 | 46 | 159 |
| 2022 11 | 113 | 41 | 154 |
| 2022 10 | 149 | 50 | 199 |
| 2022 9 | 71 | 59 | 130 |
| 2022 8 | 75 | 53 | 128 |
| 2022 7 | 64 | 55 | 119 |
| 2022 6 | 84 | 36 | 120 |
| 2022 5 | 110 | 44 | 154 |
| 2022 4 | 83 | 47 | 130 |
| 2022 3 | 94 | 67 | 161 |
| 2022 2 | 80 | 40 | 120 |
| 2021 1 | 101 | 55 | 156 |
| 2021 12 | 61 | 44 | 105 |
| 2021 11 | 74 | 55 | 129 |
| 2021 10 | 74 | 68 | 142 |
| 2021 9 | 68 | 40 | 108 |
| 2021 8 | 53 | 33 | 86 |
| 2021 7 | 47 | 28 | 75 |
| 2021 6 | 58 | 23 | 81 |
| 2021 5 | 103 | 37 | 140 |
| 2021 4 | 176 | 70 | 246 |
| 2021 3 | 108 | 34 | 142 |
| 2021 2 | 97 | 25 | 122 |
| 2020 1 | 64 | 34 | 98 |
| 2020 12 | 81 | 24 | 105 |
| 2020 11 | 63 | 27 | 90 |
| 2020 10 | 53 | 19 | 72 |
| 2020 9 | 64 | 19 | 83 |
| 2020 8 | 50 | 20 | 70 |
| 2020 7 | 44 | 21 | 65 |
| 2020 6 | 66 | 22 | 88 |
| 2020 5 | 46 | 11 | 57 |
| 2020 4 | 54 | 31 | 85 |
| 2020 3 | 41 | 28 | 69 |
| 2020 2 | 3 | 0 | 3 |
| 2020 1 | 1 | 2 | 3 |
| 2019 12 | 0 | 2 | 2 |
| 2019 11 | 9 | 0 | 9 |
| 2019 10 | 2 | 0 | 2 |
| 2019 9 | 1 | 0 | 1 |
| 2019 7 | 1 | 2 | 3 |
| 2019 6 | 1 | 2 | 3 |
| 2019 5 | 3 | 4 | 7 |
| 2019 4 | 14 | 6 | 20 |
| 2019 3 | 12 | 4 | 16 |
| 2019 2 | 33 | 11 | 44 |
| 2019 1 | 6 | 6 | 12 |
| 2018 12 | 10 | 6 | 16 |
| 2018 11 | 3 | 4 | 7 |
| 2018 10 | 14 | 5 | 19 |
| 2018 9 | 29 | 18 | 47 |
| 2018 8 | 0 | 1 | 1 |
| 2018 6 | 0 | 6 | 6 |
Mostrar todo
